Clinical Trial Update: A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma

View source ↗

Summary

A clinical trial evaluating rituximab in combination with chemotherapy for relapsed/refractory follicular lymphoma has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphoma, Follicular | Status: COMPLETED | Results posted: 2016-08-12